ABSTRACT
Objective
Pistacia lentiscus L. tree is known for its aromatic mastic gum containing terpenes α‐pinene and β‐myrcene, and has been applied as a traditional remedy in oral care for centuries. Previously, intranasal exposure to mastic resin volatiles increased salivary flow in healthy and dry‐mouth individuals. This study assessed the biological effects of oils from P. lentiscus for the purpose of standardisation and optimal performance.
Methods
Composition analysis (GC–MS/FID) and acetylcholinesterase inhibition of P. lentiscus oils obtained from resin or leaf‐twig were assessed in vitro. Salivary properties (flow, spinnbarkeit, total protein concentration) and subjective mouthfeel were analysed before and after the application of the compounds in healthy volunteers (n = 12) in the form of nasal sprays.
Results
This study confirmed that both oils tested contain compounds with acetylcholinesterase inhibitory activity in vitro. GC–MS/FID analysis showed different compositions between the resin and leaf‐twig oils. Application of leaf‐twig oil significantly increased salivary flow (median (IQR), 0.25 (0.15, 0.45) mL/min vs. 0.32 (0.19, 0.51) mL/min, p ≤ 0.01). There were no changes in spinnbarkeit, total protein concentration and mouthfeel.
Conclusions
P. lentiscus leaf‐twig oil increased salivary flow in healthy participants. Further research is required to assess its effectiveness both in large cohort and in dry mouth patients.
Keywords: dry mouth, mastic, olfactory stimulus, Pistacia lentiscus , resin, saliva
1. Introduction
Pistacia lentiscus L. is an evergreen plant of the Anacardiaceae family, cultivated for its aromatic resin (gum) in the Mediterranean region, in particular Greece, Turkey, Morocco and Algeria (Kozhoridze et al. 2015). Mastic resin is rich in terpenes that give it its characteristic woody, resinous, green, pine‐like, fresh scent (Rigling et al. 2019). α‐Pinene, β‐myrcene, limonene, β‐linalool, and perillene are the key aroma compounds that are found in mastic resin harvested on the Greek island of Chios ( P. lentiscus L. var. Chia) (Kıvçak et al. 2004; Rigling et al. 2019).
The volatile oils are harvested from various plant organs, among them twigs, leaves, and flowers, each yielding a distinct volatile composition. For example, resin oil, which is harvested from the sap found in the tree stem, is rich in α‐pinene and contains considerably less β‐myrcene when compared to the oils extracted from leaves or twigs (Magiatis et al. 1999). Furthermore, the composition of oil can be affected by the plant's region of origin, including the climate and habitat (Barra et al. 2007; Said et al. 2011; Sehaki et al. 2022; Zrira et al. 2003), plant's sex (Said et al. 2011), being a cultivated or a wild tree (Tabanca et al. 2020), vegetative stage and harvest time (Barra et al. 2007; Zrira et al. 2003), and cultivar ( P. lentiscus L. versus P. lentiscus L. var. Chia) (Kıvçak et al. 2004).
The medical application of mastic resin can be traced back to ancient times (Pachi et al. 2020). The first ever mention of mastic was most likely in “Histories” by Greek historian and geographer Herodotus in the 5th century BCE (Herodotus 2024). However, mastic resin was used even before that in Egypt, where it was detected in the embalming fluid of an Egyptian mummy from the 7th century BCE (Colombini et al. 2000). Medical researchers of antiquity, such as Dioscorides (Dioscorides 2000) and Galen (Everett 2012) mentioned various applications of mastic in their writing (Pachi et al. 2020). Among others, Dioscorides (Dioscorides 2000) recommended use of mastic gum and oil for gastrointestinal disorders and as a cleaning agent for the oral cavity. Nonetheless, mastic is still being used to this day, applied as a traditional herbal remedy (European Medicines Agency and Committee on Herbal Medicinal Products (HMPC) 2015), and also in the oral health care (Alwadi et al. 2023).
Currently, applications of mastic resin are being studied for oral care purposes, including the management of periodontal disease,oral cancer, and oral dryness, as well as dental caries prevention (Alwadi et al. 2023; Faruque et al. 2024). Novel treatments and delivery methods are needed, as the percentage of the population affected by dry mouth is growing (Agostini et al. 2018), mainly due to the side effects of medication and polypharmacy (Carpenter 2015). Yet, patients find that the products currently available on the market are not fast‐acting, and do not provide sufficient relief for dry mouth (Assy et al. 2023, 2022).
It was recently shown that nasal exposure to mastic resin volatiles significantly increases salivary flow in both healthy individuals and dry mouth patients (Faruque et al. 2023, 2024). However, for practical reasons and standardisation purposes, such as shelf‐life and ease of daily use, a more suitable delivery method is preferred. Hence, a nasal spray was selected as an alternative delivery method (Potocka et al. 2025).
The aim of this study was to assess the sialagogic properties of resin and leaf‐twig P. lentiscus oil (resin, leaf‐twig) in the form of nasal sprays acting as an olfactory stimulus in healthy individuals. Saliva quantity and composition were assessed before and after use of the compounds. Furthermore, in vitro acetylcholinesterase (AChE) inhibitory activity and volatile composition of the P. lentiscus oils were assessed.
2. Methods and Materials
2.1. Plant Material
Oils of P. lentiscus from different plant organs (leaf‐twig, resin) were used in this study (Table 1).
TABLE 1.
Information regarding compounds selected for an in vivo screening.
| Plant name | Manufacturer | Plant organ | Origin | Extraction method | CAS‐No/WFO‐ID | Batch number |
|---|---|---|---|---|---|---|
| Pistacia lentiscus L. var. Chia oil | Anemos | Resin | Chios, Greece | Steam distillation |
263‐098‐6/ wfo‐0000394118 |
ND |
| Pistacia lentiscus L. oil | NaturActive | Leaves and twigs | North Africa | Steam distillation |
ND/ wfo‐0000394118 |
2K4PK |
Abbreviation: ND, not determined.
2.2. GC–MS/FID
A total of 10 μL of essential oil was accurately weighed into a 2 mL GC vial (Agilent Technologies, Santa Clara, California, USA). A total of 1 mL of ethanol (HiPerSolv CHROMANORM grade, VWR Chemicals, West Chester, Pennsylvania, USA) was added, and 10 μL of a 1% standard of methyl decanoate (Sigma‐Aldrich, St. Louis, Missouri, USA) was transferred via pipette (Rainin LTS, Oakland, California, USA), thoroughly mixed and analysed by GC–MS/FID (Agilent Technologies).
Analysis by gas chromatography was conducted using an Agilent Technologies 8890 gas chromatograph, fitted with a purged three‐way microfluidic splitter plate (Agilent Technologies G3183B) after the primary column. The effluent was split one‐to‐one between a flame ionisation detector and an Agilent Technologies 5977B single quadrupole mass spectrometer with electron ionisation.
The column configuration comprised a SolGel‐Wax (Trajan, Ringwood, Australia) 30 m × 0.25 mm × 0.25 μm primary column. Helium (BOC, Guildford, UK) was used as the carrier gas, and the primary column flow rate was kept constant at 1 mL/min. The restrictor from the splitter to the flame ionisation detector was 1.1 m × 0.18 mm deactivated fused silica (Agilent Technologies) with a constant pressure of 3.8 PSI, and the restrictor from the splitter plate to the mass spectrometer was 2.7 m × 0.18 mm deactivated fused silica (Agilent Technologies) with a constant pressure of 3.8PSI to obtain a 1:1 split ratio. The split/splitless column inlet injector was heated to 250°C and operated in split mode (20:1 ratio) with 1 μL of sample introduced via a 10 μL syringe (Trajan) using a Centri PAL3 RTC (Markes International, Bridgend, UK). The gas chromatograph was held at 50°C (3 min), then programmed to 250°C at 5°C/min, held for 5 min. The flame ionisation detector was held constant at 275°C, the make‐up gas was purified nitrogen with a flow rate of 25 mL/min, with a purified air flow rate of 400 mL/min and 50 mL/min of hydrogen (BOC). Data were collected at 50 Hz. The mass spectrometer transfer line was held at 280°C, the ion source and quadrupole temperatures were held at 230°C and 150°C, respectively. The mass scan range was m/z 35–450 at an acquisition rate of 3.5 Hz.
Data was acquired in Agilent MassHunter Workstation and analysed using a combination of Agilent MassHunter Unknowns Analysis, AMDIS (Automated Mass Spectral Deconvolution and Identification System for GC/MS), and MassHunter Qualitative Analysis software packages using commercially available NIST23, Wiley12 and in‐house libraries along with retention indices (calculated by injection of an internal reference) to identify components. Percent by relative peak area calculated using primarily flame ionisation response, and where necessary, deconvoluted total ion count (TIC) response to allocate the proportion of coeluted components within the flame ionisation response.
The GC–MS/FID analysis of the oils was carried out by Givaudan UK.
2.3. Inhibitory Acetylcholinesterase Activity In Vitro
AChE inhibition of P. lentiscus oils was assessed using Acetylcholinesterase Inhibitor Screening Kit (MAK324, Sigma‐Aldrich, Merck, Missouri, USA) according to the manufacturer's instructions, using acetylcholinesterase from Electrophorus electricus (electric eel) (C3389, Sigma‐Aldrich, Merck, Missouri, USA) and colorimetric 96‐well plates (655191, Greiner Bio‐One, Kremsmünster, Austria). European Pharmacopoeia Reference Standard donepezil hydrochloride 0.1 mg/μL (Y0002160, EDQM, Strasbourg, France) was used as an additional standard. The final concentration of samples was 2.5% v/v. The reading was carried out using Multiskan FC Microplate Photometer (Thermo Fisher Scientific, Massachusetts, USA) at absorbance 405 nm at 0 min and at 10 min. All measurements were conducted in duplicate and repeated at least once.
2.4. Sample Preparation
Samples were prepared as described previously (Potocka et al. 2025). Plastic PET transparent nasal 30 mL spray pumps (Your Body My Concern, Raalte, the Netherlands) were used to deliver compounds. Samples were prepared by first mixing by hand one of the P. lentiscus oils (resin or leaf‐twig) with a 1:10 ratio of Tween 20 (Polysorbate) EMPROVE Essential Ph. Eur., JPE, NF (Merck, Darmstadt, Germany). Then, 0.9% NaCl solution was slowly added for a final volume of 10 mL. 0.9% NaCl solution was prepared using sodium chloride EMPROVE API Ph. Eur., BP, JP, USP (Merck, Darmstadt, Germany) and Mili‐Q water (Merck Milipore, Massachusetts, USA). Final concentrations of all compounds were 0.01%. Each spray bottle contained 10 mL of solution. The placebo spray consisted of 10 mL of 0.9% NaCl solution. Tween 20 was not added to the placebo spray as in the absence of dissolved oil compounds, it may produce a noticeable ‘soapy’ sensation associated with nasal discomfort, potentially affecting participant perception and comfort. Both sample and placebo bottles were sprayed at least 10 times before application to remove air from the pump system and ensure equal dosing. The estimated volume of each full dose (two sprays) corresponded to approximately 22 nL of resin oil and 26 nL of leaf–twig oil per administration. Assuming a typical essential oil density of approximately 0.85–0.95 g/mL, this corresponds to an estimated mass in the microgram (μg) range per dose. These values are approximate, as the exact density of the oils was not experimentally determined.
The 0.01% concentration was selected as a conservative starting dose based on earlier feasibility work with terpene‐containing olfactory stimuli and to minimise irritation risk during pilot testing.
2.5. Participants
Twelve healthy adult volunteers from Amsterdam, the Netherlands, were recruited for this pilot study, which took place between October and December 2024. All procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the local Ethical Committee of the Academic Centre for Dentistry Amsterdam with protocol no: 2022‐43674. The participants received information regarding the study both verbally and written and then gave their written informed consent and filled in a demographic information form and a health questionnaire. Only healthy subjects above the age of 18 years old were included. Exclusion criteria included: prescription medication, disorders that could affect their salivary flow, current smokers, problems with olfactory perception, current flu, allergies to any of the compounds and/or products in which these compounds could be found, rhinitis, hay feverand/or eczema, and pregnancy or lactation.
For 1 h before the experiment, the participants were instructed not to eat or drink and not to brush their teeth or use any oral care products. Furthermore, participants were asked not to wear any perfumes or other odorous products on the day of the saliva collection. During the saliva collection, participants were asked to sit straight in a resting state, not swallow the saliva, and not move or talk.
2.6. Questionnaires
Visual analogue scale (VAS) questions were set up on a 0–10 scale with responses recorded to one decimal point. Participants were asked to answer one VAS question before saliva collection: “How moist does your mouth feel at this moment?” with a scale of response from “very dry” (0) to “very moist” (10). After the experiment, participants were asked to answer two VAS questions: “How moist does your mouth feel at this moment?” with a scale of response from “very dry” (0) to “very moist” (10) and “How pleasant did you find the odour you just smelled?” with a scale of response from “very unpleasant” (0) to “very pleasant” (10).
2.7. In Vivo Exposure and Saliva Samples Collection
Saliva sampling was carried out in the morning (9:00–10:30 AM) to avoid natural variations caused by the circadian rhythm. Each participant received both compounds, each on different day (2 days total). Participants received the compounds in a randomised order and were not informed in advance which compounds they were receiving (single‐blind design). For example, participant A received P. lentiscus leaf‐twig oil on day 1 and resin oil on day 2. The study days were separated by at least 24 h, which was considered sufficient to minimise potential carryover effects, as previous work showed that the effects of mastic resin volatiles diminished within approximately 20 min after stimulation (Faruque et al. 2023). To minimise expectation bias, the nasal inhalers were prepared at a different location and kept in sealed containers until the collection of stimulated whole saliva (SWS).
Both unstimulated whole saliva (UWS) and SWS were collected by allowing saliva to accumulate at the bottom of the mouth, then drooling it into a tube after 5 min. Additionally, for SWS collection, participants were asked to administer the P. lentiscus oil/placebo solution by spraying one full pump press into each nostril (two sprays total) while inhaling at the beginning of the saliva collection. Saliva collections were carried out according to the protocol (Figure 1 ). At day 1, participants received information both written and verbally, were asked to sign the consent form, and fill in a health and “Before the experiment” questionnaire. Then, UWS—“before” was collected, followed by a 3 min break. Afterwards, placebo‐SWS was collected. This was followed by a 3 min break, and then nasal spray (resin or leaf‐twig)—“after” SWS was collected. At the end, participants filled in the questionnaire “After the experiment”. During day 2, “Before the experiment” questionnaires were filled out, then UWS—“before” was collected, followed by a 3 min break. Afterwards, SWS using nasal spray (resin or leaf‐twig)—“after”, was collected. At the end, participants filled in the questionnaire “After the experiment”.
FIGURE 1.

Schematic protocol of the olfactory stimulation measurements in volunteers. SWS, stimulated whole saliva; UWS, unstimulated whole saliva.
2.8. Spinnbarkeit Measurements
After the collection, saliva samples were kept on ice, and shortly before the spinnbarkeit measurements, vortexed for 3 s. Salivary spinnbarkeit was measured using the Neva meter (Ishikawa Iron Works Corporation, Tokyo, Japan, (Gohara et al. 2004)) according to a previously published protocol (Potocka et al. 2025). The device was set to “dry mode”, measure speed: 0.50 mm/s, dip depth: 0.95 mm, hold time up: 1 s, hold time down: 10 s and the detection method: optical. Measurements were performed in quintuplicates using 80 μL of saliva. The average value (in mm) was calculated by excluding the highest and lowest readings and averaging the remaining three.
2.9. Total Protein Concentration
Total protein content was measured using Pierce Bicinchoninic acid assay (BCA) Protein Assay Kit (Thermo Fisher Scientific, Massachusetts, USA) and 96‐well polystyrene microplates (Greiner Bio‐One, Frickenhausen, Germany), according to the manufacturer's protocol. Bovine serum albumin was used as a standard. The absorbance was measured at 562 nm using the Multiskan FC Microplate Photometer. The total protein concentration was calculated according to the manufacturer's protocol. The assay was carried out in replicates.
2.10. Statistical Analysis
The statistical analysis was carried out using GraphPad Prism (Dotmatics, Massachusetts, USA). Normality of data was assessed using the Shapiro–Wilk test (p < 0.05). Values are reported as mean ± SD (normally distributed data), unless stated otherwise. Values of p < 0.05 were considered statistically significant.
Statistical analysis was carried out between “before” and “after” measurements to account for interpersonal differences between participants and any fluctuations occurring from measurements on different days. Differences in subjective mouth feeling, pleasantness of scents and total protein concentration were assessed by paired t‐test (normally distributed data). Differences in salivary flow and spinnbarkeit were assessed by a paired Wilcoxon test (not normally distributed data). Correlation between salivary flow and pleasantness of the compounds was calculated using Spearman's rank correlation coefficient. Post hoc effect size was estimated using G*Power 3.1.9.7 (Heinrich‐Heine‐Universität Düsseldorf, Düsseldorf, Germany), selecting the Wilcoxon signed‐rank test (matched pairs), parent distribution “min ARE” (not normally distributed data) or “normal” (normally distributed data), two tails, α err prob. 0.05, and total sample size n = 12.
3. Results
3.1. Volatile Composition and Inhibitory Acetylcholinesterase Activity In Vitro
The main compounds of resin oil were identified as (flame ionisation detector percentage (%FID) by relative peak area (RPA)) α‐pinene (82.89%), β‐myrcene (8.38%) and β‐pinene (2.12%) (Table 2). For leaf‐twig oil, α‐pinene was the main compound (21.32%), followed by β‐myrcene (17.65%) and D‐limonene (15.91%) (Table 2). Full results of the analysis can be found in Tables S1 and S2. At the concentration of 2.5% v/v, both oils of P. lentiscus (resin, leaf‐twig) were found to nearly completely inhibit AChE under the assay conditions.
TABLE 2.
Volatile composition of the Pistacia lentiscus resin (mastic) and leaf‐twig oils.
| Compound name | CAS# | FID % by RPA |
|---|---|---|
| Pistacia lentiscus resin (mastic) oil | ||
| α‐pinene | 80‐56‐8 | 82.89 |
| β‐myrcene | 123‐35‐3 | 8.38 |
| β‐pinene | 18172‐67‐3 | 2.12 |
| α‐pinene oxide | 1686‐14‐2 | 0.92 |
| Trans‐verbenol | 1820‐09‐3 | 0.71 |
| Cis‐verbenol | 1845‐30‐3 | 0.7 |
| D‐limonene | 5989‐27‐5 | 0.62 |
| Camphene | 79‐92‐5 | 0.54 |
| Perillene | 539‐52‐6 | 0.4 |
| 2‐methylanisole | 578‐58‐5 | 0.36 |
| Pistacia lentiscus leaf‐twig oil | ||
| α‐pinene | 80‐56‐8 | 21.32 |
| β‐myrcene | 123‐35‐3 | 17.65 |
| D‐limonene | 5989‐27‐5 | 15.91 |
| Terpinen‐4‐ol | 562‐74‐3 | 6.72 |
| P‐cymene | 99‐87‐6 | 5.74 |
| Caryophyllene | 87‐44‐5 | 4.29 |
| α‐terpineol | 98‐55‐5 | 3.53 |
| β‐pinene | 18172‐67‐3 | 3.02 |
| Camphene | 79‐92‐5 | 2.22 |
| β‐phellandrene | 555–10‐2 | 2.13 |
Abbreviations: %FID, flame ionisation detector percentage; RPA, relative peak area.
3.2. In Vivo Pilot Study Cohort
A total of 12 healthy volunteers (30.17 ± 8.94 years, range 19–45 years) took part in this study, including 6 females (29.17 ± 8.80 years, range 20–44 years) and 6 males (31.17 ± 9.81 years, range 19–45 years).
3.3. Salivary Flow and Extensional Rheology (Spinnbarkeit)
Ortho‐nasal stimulation with the compounds resulted in a significant increase in salivary flow rates after the application of leaf‐twig oil (median (IQR), UWS 0.25 (0.15, 0.45) mL/min vs. SWS 0.32 (0.19, 0.51) mL/min, effect size 0.67, p ≤ 0.01) (Figure 2). The salivary flow did not change after stimulation with the resin oil (UWS 0.26 (0.12, 0.41) mL/min vs. SWS 0.26 (0.19, 0.54) mL/min). There was no observed placebo effect (UWS 0.28 (0.14, 0.39) mL/min vs. SWS 0.30 (0.17, 0.43) mL/min).
FIGURE 2.

Salivary flow (mL/min) before (UWS—unstimulated whole saliva) and after stimulation with P. lentiscus oils: resin and leaf‐twig (SWS—stimulated whole saliva) by nasal spray in healthy participants (n = 12). Values are expressed as median ± IQR. Paired Wilcoxon test. **p ≤ 0.01.
Spinnbarkeit did not change before and after application of P. lentiscus leaf‐twig oil (UWS 17.00 (6.82, 40.26) mm vs. SWS 24.26 (4.15, 57.78) mm), and resin oil (UWS 14.01 (5.71, 52.67) mm vs. SWS 15.38 (4.86, 77.20) mm).
3.4. Total Protein Concentration
The analysis of total salivary protein concentration revealed no difference between before and after the application of resin (UWS 939.52 ± 323.98 μg/mL vs. SWS 921.11 ± 398.72 μg/mL) and leaf‐twig (UWS 929.70 ± 302.86 μg/mL vs. SWS 906.19 ± 309.74 μg/mL).
3.5. Mouth Feeling and Pleasantness of the Scents
There was no difference in mouth feeling before and after the application of the P. lentiscus leaf‐twig oil (UWS 4.67 ± 1.24 vs. SWS 4.54 ± 1.24) and the resin oil (UWS 4.78 ± 1.22 vs. SWS 4.63 ± 1.63). Scent of resin oil (6.32 ± 1.86) was found to be significantly more pleasant than the scent of leaf‐twig oil (4.13 ± 1.92) (effect size 1.12, p ≤ 0.01) (Figure 3). There was no correlation between salivary flow and pleasantness of the compounds (resin oil r = −0.17, leaf‐twig oil r = 0.57).
FIGURE 3.

Score of the pleasantness after the stimulation with nasal spray with P. lentiscus resin and leaf‐twig oils in healthy participants (n = 12). The feeling was scored using VAS from 0 (“very unpleasant”) to 10 (“very pleasant”) in response to a question “How pleasant did you find the odour you just smelled?”. Values are expressed as mean ± SD. Paired t‐test. **p ≤ 0.01.
4. Discussion
This study assessed the sialagogic properties of P. lentiscus oils obtained from different plant organs: resin, which is secreted by the stem of the plant, or from young, green plant parts such as leaves and twigs. For standardisation and handling purposes, the oils were diluted and dispersed in the nasal cavity using nasal sprays. The exposure to the leaf‐twig oil increased the salivary flow in vivo, in contrast to the resin‐derived oil. No differences in spinnbarkeit and subjective perception were observed after the application of oils. Furthermore, resin oil was found to be significantly more pleasant than the leaf‐twig oil. Pleasantness did not have an influence on the salivary flow outcomes.
Salivary output is modulated by a combination of regulatory pathways. Primarily, saliva secretion is regulated by the autonomic nervous system. During parasympathetic autonomic nerve stimulation, AChE inhibitors decrease the breakdown of AChE, resulting in an increase or prolongation of parasympathetic neurotransmission and subsequent stimulation of salivary flow (Proctor and Carpenter 2007). Secretion is also regulated via transient receptor potential (TRP) channels in response to different stimuli (Liu et al. 2018) and acinar cell secretion via Ca2+‐ dependent mechanisms (Ambudkar 2014).
To better understand the potential mode of action of the active compounds, an analysis of the composition was carried out. The composition of the oils analysed was consistent with the previous literature reports on specimens collected in the same regions (Pachi et al. 2021; Ramdani et al. 2016). α‐Pinene was found to be the main compound of both oils harvested from resin and from green plant parts (leaves and twigs). However, resin oil contained around four times more α‐pinene than leaf‐twig oil. α‐Pinene is a weak AChE inhibitor (Dohi et al. 2009; Miyazawa and Yamafuji 2005), and its ability to increase salivary flow is thought to occur through AChE inhibition (Dohi et al. 2009; Miyazawa and Yamafuji 2005).
The second most abundant compound, β‐myrcene, has weak AChE inhibitory properties (Burčul et al. 2020). Leaf‐twig oil contained about twice as much β‐myrcene as the resin oil. β‐myrcene is thought to be modulating TRP vanilloid 1 (TRPV1) channels. It has to be noted that the data proving this ability are conflicting (Heblinski et al. 2020; Jansen et al. 2019). TRPV1 receptors are heat‐activated ion channels that contribute to the transmission and modulation of nociceptive signals (e.g., capsaicin) (Rosenbaum and Simon 2007). In addition to the sensory role, TRPV1 channels have a function in store‐operated Ca2+ entry (SOCE) mechanism, which is involved in regulating salivary fluid secretion (Ambudkar 2014; Liu et al. 2018). In recent studies, TRPV1 agonists such as capsaicin (Gardner et al. 2020; Pushpass et al. 2019) or nonivamide (Houghton et al. 2020) have been shown to increase salivary flow in humans.
D‐limonene, which can be found abundantly in citrus peels, is the third most abundant monoterpene in the leaf‐twig oil. Limonene is not a strong AChE inhibitor (Burčul et al. 2020), nor is it thought to be able to bind to TRPV1 channels (Kaimoto et al. 2016). It was demonstrated to inhibit transient receptor potential ankyrin 1 (TRPA1) channel (Kaimoto et al. 2016), but the role of TRPA1 channels in salivation is not well understood (Houghton et al. 2020; Liu et al. 2018). In patients with radiation‐induced xerostomia, D‐limonene improved patient outcomes by activating aldehyde dehydrogenase 3A1 (ALDH3A1), which preserves salivary gland structure and function following the radiation treatment (Saiki et al. 2018; Wright et al. 2025).
The minor constituents of the oils might also be playing a role in the salivary stimulation. Minor constituents with low odour thresholds may disproportionately influence olfactory‐driven autonomic responses. Although the composition analysis in this study primarily focused on monoterpenes, plant essential oils contain a range of other bioactive constituents, including polyphenols (e.g., flavonoids), terpenes (e.g., sesquiterpenes) and terpenoids (e.g., oxygenated monoterpenes) (Arzani et al. 2025).
Importantly, the concentration used in vitro (2.5% v/v) was substantially higher than the estimated exposure levels achieved via nasal administration (0.01% formulation, with nanolitre quantities per dose), indicating that direct AChE inhibition is unlikely to fully explain the observed in vivo effect. Moreover, both oils demonstrated similar AChE inhibition in vitro, whereas only the leaf–twig oil increased salivary flow in vivo, further suggesting that additional mechanisms are involved. The sialagogic effect of P. lentiscus leaf–twig oil may be attributed to the synergistic effects of its diverse terpenic constituents with muscarinic and TRP receptors.
These findings are in parallel with the results of Faruque et al. (2024), who demonstrated a positive effect of mastic resin volatiles delivered in the form of natural resin on the salivary flow. However, in contrast to the current study, no effect was observed after the use of the mastic resin oil. This difference may be explained by two key factors: the composition of the resin oil and the delivery method. First, the chemical composition of P. lentiscus resin oil can vary significantly depending on its geographic origin. In this study, the resin oil was sourced from P. lentiscus trees from the island of Chios in Greece, whereas Faruque et al. used resin from Pistacia trees growing in Iran (resin composition not determined). Second, differences in the method of delivery may also have played a role. Faruque et al. used volatiles from freeze‐dried crushed resin in sachets, while in this study, the oils were administered as a 0.01% solution using nasal sprays. This methodological difference could influence the distribution and concentration of the active molecules binding to the receptors in the oronasal cavity, and consequently, their final effect on the salivary flow.
A primary limitation of this study is the relatively small sample size, which is attributable to its pilot‐study design. Besides, the observed effects of the compounds are limited to short‐term outcomes, and long‐term effects need to be evaluated. The findings of this study apply to outcomes in a population of healthy volunteers, and further research is required to determine the effects in dry‐mouth patients. Furthermore, the compositional data obtained from GC–MS/FID analysis are presented as relative peak area percentages, which provide semi‐quantitative information, as the values are relative proportions, not absolute concentrations. This may be influenced by compound‐specific response factors. In addition, the analysis was carried out on a single batch of each oil, which does not take into consideration batch‐to‐batch variation. Future studies require tolerability testing and dose escalation to appropriately evaluate concentrations of the compounds.
Next steps in this research should include re‐assessing the scent profiles and composition of the compound solutions, dosage optimisation, determination of the long‐term effects of the compounds and an assessment in a larger healthy cohort, and then further in a dry mouth patient cohort.
5. Conclusions
In conclusion, this study showed the potential of P. lentiscus leaf‐twig oil as a sialagogue in healthy participants. Yet further research is required to improve the scent profile and delivery method of the treatment and determine the long‐term effects in both healthy and dry‐mouth cohorts.
Author Contributions
Luca van Eijndthoven: validation, methodology, formal analysis, investigation, writing – review and editing. Marja L. Laine: conceptualization, validation, resources, writing – review and editing, supervision, funding acquisition, project administration. Zainab Assy: conceptualization, validation, methodology, formal analysis, investigation, writing – review and editing, supervision, project administration. Floris J. Bikker: conceptualization, validation, resources, writing – review and editing, supervision, project administration, funding acquisition. Wiktoria Potocka: conceptualization, methodology, validation, formal analysis, investigation, data curation, writing – original draft, visualization, project administration, writing – review and editing.
Funding
This research was funded by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) grant number 19217.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Table S1: Volatile composition of the Pistacia lentiscus resin (mastic) oil. %FID—flame ionisation detector percentage, RPA—relative peak area, RT—retention time.
Table S2: Volatile composition of the Pistacia lentiscus leaf‐twig oil. %FID—flame ionisation detector percentage, RPA—relative peak area, RT—retention time.
Data Availability Statement
The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request. https://doi.org/10.48338/VU01‐ST8I43
References
- Agostini, B. A. , Cericato G. O., da Silveira E. R., et al. 2018. “How Common Is Dry Mouth? Systematic Review and Meta‐Regression Analysis of Prevalence Estimates.” Brazilian Dental Journal 29, no. 6: 606–618. 10.1590/0103-6440201802302. [DOI] [PubMed] [Google Scholar]
- Alwadi, M. A. M. , Sidhu A., Khaled M. B., and Aboul‐Enein B. H.. 2023. “Mastic ( Pistacia lentiscus ) Gum and Oral Health: A State‐Of‐The‐Art Review of the Literature.” Journal of Natural Medicines 77, no. 3: 430–445. 10.1007/s11418-023-01704-y. [DOI] [PubMed] [Google Scholar]
- Ambudkar, I. S. 2014. “Ca2+ Signaling and Regulation of Fluid Secretion in Salivary Gland Acinar Cells.” Cell Calcium 55, no. 6: 297–305. 10.1016/j.ceca.2014.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arzani, V. , Soleimani M., Fritsch T., Jacob U. M., Calabrese V., and Arzani A.. 2025. “Plant Polyphenols, Terpenes, and Terpenoids in Oral Health.” Open Medicine 20, no. 1: 20251183. 10.1515/med-2025-1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Assy, Z. , Bikker F. J., Mashhour E., Asadi M., and Brand H. S.. 2022. “Preferences of Sjögren's Syndrome Patients Regarding Potential New Saliva Substitutes.” Clinical Oral Investigations 26, no. 10: 6245–6252. 10.1007/s00784-022-04576-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Assy, Z. , Van Santen J. S., Brand H. S., and Bikker F. J.. 2023. “Use and Efficacy of Dry‐Mouth Interventions in Sjögren's Disease Patients and Possible Association With Perceived Oral Dryness and Patients' Discomfort.” Clinical Oral Investigations 27, no. 9: 5529–5537. 10.1007/s00784-023-05172-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barra, A. , Coroneo V., Dessi S., Cabras P., and Angioni A.. 2007. “Characterization of the Volatile Constituents in the Essential Oil of Pistacia lentiscus L. From Different Origins and Its Antifungal and Antioxidant Activity.” Journal of Agricultural and Food Chemistry 55, no. 17: 7093–7098. 10.1021/jf071129w. [DOI] [PubMed] [Google Scholar]
- Burčul, F. , Blažević I., Radan M., and Politeo O.. 2020. “Terpenes, Phenylpropanoids, Sulfur and Other Essential Oil Constituents as Inhibitors of Cholinesterases.” Current Medicinal Chemistry 27, no. 26: 4297–4343. 10.2174/0929867325666180330092607. [DOI] [PubMed] [Google Scholar]
- Carpenter, G. , ed. 2015. Dry Mouth: A Clinical Guide on Causes, Effects and Treatments. Springer. 10.1007/978-3-642-55154-3. [DOI] [Google Scholar]
- Colombini, M. P. , Modugno F., Silvano F., and Onor M.. 2000. “Characterization of the Balm of an Egyptian Mummy From the Seventh Century B.C.” Studies in Conservation 45: 19–29. [Google Scholar]
- Dioscorides, P. 2000. De Materia Medica, edited by Osbaldeston T. A. and Wood R. P. A.. Ibidis Press. [Google Scholar]
- Dohi, S. , Terasaki M., and Makino M.. 2009. “Acetylcholinesterase Inhibitory Activity and Chemical Composition of Commercial Essential Oils.” Journal of Agricultural and Food Chemistry 57, no. 10: 4313–4318. 10.1021/jf804013j. [DOI] [PubMed] [Google Scholar]
- European Medicines Agency , and Committee on Herbal Medicinal Products (HMPC) . 2015. Assessment Report on Pistacia lentiscus L., Resin (Mastix). European Medicines Agency. [Google Scholar]
- Everett, N. 2012. The Alphabet of Galen: Pharmacy From Antiquity to the Middle Ages: A Critical Edition of the Latin Text With English Translation and Commentary. University of Toronto Press. [Google Scholar]
- Faruque, M. R. J. , Nazmi K., van Splunter A., Laine M., and Bikker F.. 2023. “Sialagogic Effects Through Olfactory Stimulation With Mastic Resin and α‐Pinene Volatiles In Vivo.” Biomedicine & Pharmacotherapy 168: 115699. 10.1016/j.biopha.2023.115699. [DOI] [PubMed] [Google Scholar]
- Faruque, M. R. J. , Potocka W., Nazmi K., Ligtenberg A. J., Bikker F. J., and Laine M. L.. 2024. “Scent of Relief: Mastic Resin Scent Recovers Salivation in Chronic Dry Mouth Patients.” Biomedicine & Pharmacotherapy 178: 117245. 10.1016/j.biopha.2024.117245. [DOI] [PubMed] [Google Scholar]
- Gardner, A. , So P., and Carpenter G.. 2020. “Endogenous Salivary Citrate Is Associated With Enhanced Rheological Properties Following Oral Capsaicin Stimulation.” Experimental Physiology 105, no. 1: 96–107. 10.1113/EP088166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gohara, K. , Ansai T., Koseki T., et al. 2004. “A New Automatic Device for Measuring the Spinnbarkeit of Saliva: The Neva Meter.” Journal of Dentistry 32, no. 4: 335–338. 10.1016/j.jdent.2004.01.006. [DOI] [PubMed] [Google Scholar]
- Heblinski, M. , Santiago M., Fletcher C., et al. 2020. “Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels.” Cannabis and Cannabinoid Research 5, no. 4: 305–317. 10.1089/can.2019.0099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herodotus. 2024. Histories, edited by Macaulay G. C.. Standard Ebooks. https://standardebooks.org/ebooks/herodotus/histories/g‐c‐macaulay. [Google Scholar]
- Houghton, J. W. , Carpenter G., Hans J., Pesaro M., Lynham S., and Proctor G.. 2020. “Agonists of Orally Expressed TRP Channels Stimulate Salivary Secretion and Modify the Salivary Proteome.” Molecular & Cellular Proteomics: MCP 19, no. 10: 1664–1676. 10.1074/mcp.RA120.002174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jansen, C. , Shimoda L. M. N., Kawakami J. K., et al. 2019. “Myrcene and Terpene Regulation of TRPV1.” Channels 13, no. 1: 344–366. 10.1080/19336950.2019.1654347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaimoto, T. , Hatakeyama Y., Takahashi K., Imagawa T., Tominaga M., and Ohta T.. 2016. “Involvement of Transient Receptor Potential A1 Channel in Algesic and Analgesic Actions of the Organic Compound Limonene.” European Journal of Pain 20, no. 7: 1155–1165. 10.1002/ejp.840. [DOI] [PubMed] [Google Scholar]
- Kıvçak, B. , Akay S., Demirci B., and Başer K.. 2004. “Chemical Composition of Essential Oils From Leaves and Twigs of Pistacia lentiscus , Pistacia lentiscus Var. Chia, and Pistacia terebinthus From Turkey.” Pharmaceutical Biology 42, no. 4–5: 360–366. 10.1080/13880200490519677. [DOI] [Google Scholar]
- Kozhoridze, G. , Orlovsky N., Orlovsky L., Blumberg D. G., and Golan‐Goldhirsh A.. 2015. “Geographic Distribution and Migration Pathways of Pistacia – Present, Past and Future.” Ecography 38, no. 11: 1141–1154. 10.1111/ecog.01496. [DOI] [Google Scholar]
- Liu, X. , Ong H. L., and Ambudkar I.. 2018. “TRP Channel Involvement in Salivary Glands—Some Good, Some Bad.” Cells 7, no. 7: 74. 10.3390/cells7070074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Magiatis, P. , Melliou E., Skaltsounis A.‐L., Chinou I., and Mitaku S.. 1999. “Chemical Composition and Antimicrobial Activity of the Essential Oils of Pistacia lentiscus Var. Chia.” Planta Medica 65, no. 8: 749–752. 10.1055/s-2006-960856. [DOI] [PubMed] [Google Scholar]
- Miyazawa, M. , and Yamafuji C.. 2005. “Inhibition of Acetylcholinesterase Activity by Bicyclic Monoterpenoids.” Journal of Agricultural and Food Chemistry 53, no. 5: 1765–1768. 10.1021/jf040019b. [DOI] [PubMed] [Google Scholar]
- Pachi, V. K. , Mikropoulou E. V., Dimou S., et al. 2021. “Chemical Profiling of Pistacia lentiscus Var. Chia Resin and Essential Oil: Ageing Markers and Antimicrobial Activity.” PRO 9, no. 3: 418. 10.3390/pr9030418. [DOI] [Google Scholar]
- Pachi, V. K. , Mikropoulou E. V., Gkiouvetidis P., et al. 2020. “Traditional Uses, Phytochemistry and Pharmacology of Chios Mastic Gum ( Pistacia lentiscus Var. Chia, Anacardiaceae): A Review.” Journal of Ethnopharmacology 254: 112485. 10.1016/j.jep.2019.112485. [DOI] [PubMed] [Google Scholar]
- Potocka, W. , Assy Z., van Splunter A. P., Laine M. L., and Bikker F. J.. 2025. “From Scent to Saliva: The Saliva‐Stimulating Effect of Terpenes in Dry Mouth.” Archives of Oral Biology 175: 106282. 10.1016/j.archoralbio.2025.106282. [DOI] [PubMed] [Google Scholar]
- Proctor, G. B. , and Carpenter G. H.. 2007. “Regulation of Salivary Gland Function by Autonomic Nerves.” Autonomic Neuroscience 133, no. 1: 3–18. 10.1016/j.autneu.2006.10.006. [DOI] [PubMed] [Google Scholar]
- Pushpass, R.‐A. G. , Daly B., Kelly C., Proctor G., and Carpenter G. H.. 2019. “Altered Salivary Flow, Protein Composition, and Rheology Following Taste and TRP Stimulation in Older Adults.” Frontiers in Physiology 10: 652. 10.3389/fphys.2019.00652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramdani, M. , Bergoug R., Chalard P., et al. 2016. Chemotype and Antibacterial Activity of Algerian Populations of Pistacia lentiscus L. INTERNATIONAL JOURNAL OF PHYTOPHARMACY RESEARCH; Vol. 7. [Google Scholar]
- Rigling, M. , Fraatz M. A., Trögel S., Sun J., Zorn H., and Zhang Y.. 2019. “Aroma Investigation of Chios Mastic Gum ( Pistacia lentiscus Variety Chia) Using Headspace Gas Chromatography Combined With Olfactory Detection and Chiral Analysis.” Journal of Agricultural and Food Chemistry 67, no. 49: 13420–13429. 10.1021/acs.jafc.9b00143. [DOI] [PubMed] [Google Scholar]
- Rosenbaum, T. , and Simon S. A.. 2007. “TRPV1 Receptors and Signal Transduction.” In TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades, edited by Liedtke W. B. and Heller S.. CRC Press/Taylor & Francis. [PubMed] [Google Scholar]
- Said, S. A. , Fernandez C., Greff S., et al. 2011. “Inter‐Population Variability of Terpenoid Composition in Leaves of Pistacia lentiscus L. From Algeria: A Chemoecological Approach.” Molecules 16, no. 3: 2646–2657. 10.3390/molecules16032646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saiki, J. P. , Cao H., Van Wassenhove L. D., et al. 2018. “Aldehyde Dehydrogenase 3A1 Activation Prevents Radiation‐Induced Xerostomia by Protecting Salivary Stem Cells From Toxic Aldehydes.” Proceedings of the National Academy of Sciences of the United States of America 115, no. 24: 6279–6284. 10.1073/pnas.1802184115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sehaki, C. , Jullian N., Choque E., et al. 2022. “Profiling of Essential Oils From the Leaves of Pistacia lentiscus Collected in the Algerian Region of Tizi‐Ouzou: Evidence of Chemical Variations Associated With Climatic Contrasts Between Littoral and Mountain Samples.” Molecules 27, no. 13: 4148. 10.3390/molecules27134148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tabanca, N. , Nalbantsoy A., Kendra P. E., Demirci F., and Demirci B.. 2020. “Chemical Characterization and Biological Activity of the Mastic Gum Essential Oils of Pistacia lentiscus var. Chia From Turkey.” Molecules 25, no. 9: 2136. 10.3390/molecules25092136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright, L. , Wignall A., Subramaniam S., Schultz H. B., Joyce P., and Prestidge C. A.. 2025. “Enhanced Oral Absorption and Biodistribution to Submandibular Salivary Glands of D‐Limonene in Sprague Dawley Rats via a Liquid‐Lipid Formulation Approach.” International Journal of Pharmaceutics 670: 125179. 10.1016/j.ijpharm.2025.125179. [DOI] [PubMed] [Google Scholar]
- Zrira, S. , Elamrani A., and Benjilali B.. 2003. “Chemical Composition of the Essential Oil of Pistacia lentiscus L. From Morocco—A Seasonal Variation.” Flavour and Fragrance Journal 18, no. 6: 475–480. 10.1002/ffj.1221. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Table S1: Volatile composition of the Pistacia lentiscus resin (mastic) oil. %FID—flame ionisation detector percentage, RPA—relative peak area, RT—retention time.
Table S2: Volatile composition of the Pistacia lentiscus leaf‐twig oil. %FID—flame ionisation detector percentage, RPA—relative peak area, RT—retention time.
Data Availability Statement
The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request. https://doi.org/10.48338/VU01‐ST8I43
